Content about Centocor

September 10, 2013

European regulators have approved the European Union's first biosimilar monoclonal antibody. The new product, made by U.S.-based Hospira, comes seven years after the approval of Europe's first biosimilar.

May 15, 2013

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating ulcerative colitis, the agency said Wednesday.

April 16, 2013

Johnson & Johnson's sales increased by 8.5% to $17.5 billion in first quarter 2013, the healthcare products company said Tuesday.

January 28, 2013

Johnson & Johnson is shopping its women's health unit, according to a report Friday in The Wall Street Journal, which suggested that the business no longer coincided with J&J's "growth priorities."

December 6, 2012

Johnson & Johnson is seeking approval from the Food and Drug Administration for a drug to treat active psoriatic arthritis, the company said Thursday.

December 3, 2012

Johnson & Johnson has announced that Alex Gorsky will assume, effective Dec. 28, the chairman title and additional leadership responsibilities for the global health care company.

October 22, 2012

More patients with an inflammatory disease of the bowels responded to a drug used for autoimmune disorders than those taking a placebo, according to results of a late-stage clinical trial announced Monday.

October 9, 2012

The Food and Drug Administration has approved a drug made by Acton Pharmaceuticals for asthma, the company said.

September 19, 2012

A subsidiary of Johnson & Johnson is hoping to gain Food and Drug Administration approval for a new formulation of one of its drugs.

August 23, 2012

A division of Johnson & Johnson has started a late-stage clinical trial program for a drug for rheumatoid arthritis under a partnership with British drug maker GlaxoSmithKline.

July 17, 2012

A subsidiary of Johnson & Johnson is hoping to win an additional approval for one of its drugs.

May 24, 2012

Findings from a new study indicate that more than half of the patients with ulcerative colitis who received subcutaneous injections of a drug used to treat autoimmune disorders responded to the treatment.

February 22, 2012

Johnson & Johnson on Tuesday named Alex Gorsky CEO of the company, effective April 26, the date of the company’s annual meeting of shareholders.

January 25, 2012

Johnson & Johnson is preparing to turn the corner with its McNeil Consumer Healthcare business, J&J chairman and CEO William Weldon told analysts during the company's fourth-quarter earnings call Tuesday.

December 20, 2011

The market for drugs to treat ulcerative colitis will increase from 2010's $1.7 billion to $3 billion in 2020, according to a new report by market research firm Decision Resources.

September 26, 2011

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating ulcerative colitis in children.

July 22, 2011

A panel of experts at the Food and Drug Administration has recommended that the agency approve a drug made by Johnson & Johnson as a treatment for ulcerative colitis in children.

July 7, 2011

Johnson & Johnson on Thursday announced that the company has entered into an agreement to become a global sponsor of the 2014 FIFA World Cup Brazil, becoming the eighth and final FIFA World Cup Sponsor.

December 15, 2010

Johnson & Johnson on Wednesday announced that Alex Gorsky, currently worldwide chairman of medical devices and diagnostics, and Sheri McCoy, currently worldwide chairman of pharmaceuticals, have been appointed vice chairmen of the executive committee, joining William Weldon, J&J chairman and CEO, in an expanded Office of the Chairman.

October 4, 2010

The drug market for ulcerative colitis treatments will see modest growth through 2019, according to...

September 30, 2010

McNeil products soon will repopulate shelves, Johnson & Johnson chairman and CEO Bill Weldon shared...

September 29, 2010

The biotech division of Johnson & Johnson is hoping to expand the use of a...

September 28, 2010

The drug market for Crohn's disease treatments will see moderate growth over the next decade,...

September 15, 2010

House Committee on Oversight and Government Reform chairman Ed Towns, D-N.Y., on Thursday announced that...

© 2014 Drug Store News. All Rights Reserved.